The Humanoid Price War

In two years, the price of a Chinese humanoid robot fell further than most people thought possible. Unitree’s average selling price dropped roughly 72%, from about 593,400 yuan (~$85,000) in 2023 to 167,600 yuan (~$25,000) in 2025.^[1] Its budget G1, launched in 2024, starts at $16,000, less than a small sedan, a price reached by stripping out wires, chips and screws rather than performance.^[2]

Price is a strategy here, not an accident. Unitree’s revenue rose from 392 million yuan in 2024 to 1.71 billion in 2025, it shipped around 5,500 humanoids, and it still held a gross margin near 60%, the payoff from making its own actuators and motors in-house.^[1] In August 2026 it raised roughly $900 million in a Shanghai STAR Market listing, the first onshore humanoid IPO, with the retail tranche oversubscribed more than 8,000 times and the stock up 542% on debut.^[3][4]

A humanoid that costs less than a small car, from a company with a 60% gross margin. The price is the product.

From demo to deployment

The robots are leaving the stage. UBTech began mass production of its full-size Walker S2 in November 2025, with cumulative orders past 800 million yuan and units deploying on the lines of BYD, Geely, FAW-Volkswagen, Foxconn and SF Express; it targets 500 units in 2025, 5,000 in 2026 and 10,000 by 2027.^[5]

Vertical integration is the quiet reason the price war is survivable. Because Unitree makes its own actuators and motors, each price cut compresses a margin it controls rather than one it pays a supplier for, which is how it can hold a gross margin near 60% while undercutting rivals. UBTech is running the opposite play: rather than win on the cheapest unit, it is racing to lock in enterprise deployments on real production lines, where switching costs and integration work build a moat that a lower sticker price cannot easily dislodge. Two strategies, one curve: and the market will reward whichever compounds faster.

Why it matters for investors

A price war this steep changes the question. The issue is no longer whether a capable humanoid can be built cheaply (Chinese makers have answered that) but who can manufacture at volume with defensible margins, and which component suppliers become the picks-and-shovels of the ramp. Vertical integration (Unitree) and enterprise deployment (UBTech) are two bets on the same curve. We track unit economics and order books, not stage demos: the companies that survive a price war are the ones that own their cost structure.